Literature DB >> 7787452

[Trypanosomiasis from Trypanosoma brucei gambiense in the center of north-west Uganda. Evaluation of 5 years of control (1987-1991)].

C Paquet1, J Castilla, D Mbulamberi, M F Beaulieu, M G Gastellu Etchegorry, A Moren.   

Abstract

In Uganda, a case-finding and treatment programme has been implemented by Médecine Sans Frontières (MSF) and the Ministry of Health in the North of West-Nile province. Data collected in the hospital of Moyo from January 1987 to June 1991 were analyzed. Forty eight hundred and twenty two cases of trypanosomiasis due to T. B. gambiense has been recorded. Cumulative incidence rate for this period was 5.6%. Passive and active case-finding strategies were used, both based on Card Agglutination Test (CATT) as screening tool, followed by parasitological examinations. The mobile teams identified 1906 of the 4,822 cases (39.5%). Case fatality rate was 2.6%. This study confirmed the association between social and political disruptions, large movements of population and extension of trypanosomiasis. Active case-finding seems to quickly reduce disease prevalence in hyper-endemic areas. An integrated programme is then necessary to control sleeping sickness transmission.

Entities:  

Mesh:

Year:  1995        PMID: 7787452

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  9 in total

1.  Sleeping sickness in Uganda: a thin line between two fatal diseases.

Authors:  Kim Picozzi; Eric M Fèvre; Martin Odiit; Mark Carrington; Mark C Eisler; Ian Maudlin; Susan C Welburn
Journal:  BMJ       Date:  2005-11-26

2.  Prevalence and under-detection of gambiense human African trypanosomiasis during mass screening sessions in Uganda and Sudan.

Authors:  Francesco Checchi; Andrew P Cox; François Chappuis; Gerardo Priotto; Daniel Chandramohan; Daniel T Haydon
Journal:  Parasit Vectors       Date:  2012-08-07       Impact factor: 3.876

3.  Should I get screened for sleeping sickness? A qualitative study in Kasai province, Democratic Republic of Congo.

Authors:  Alain Mpanya; David Hendrickx; Mimy Vuna; Albert Kanyinda; Crispin Lumbala; Valéry Tshilombo; Patrick Mitashi; Oscar Luboya; Victor Kande; Marleen Boelaert; Pierre Lefèvre; Pascal Lutumba
Journal:  PLoS Negl Trop Dis       Date:  2012-01-17

4.  Trypanosomiasis control, Democratic Republic of Congo, 1993-2003.

Authors:  Pascal Lutumba; Jo Robays; Constantin Miaka mia Bilenge; Victor Kande Betu Ku Mesu; Didier Molisho; Johan Declercq; Wim Van der Veken; Filip Meheus; Jean Jannin; Marleen Boelaert
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

5.  The impact of passive case detection on the transmission dynamics of gambiense Human African Trypanosomiasis.

Authors:  Francesco Checchi; Sebastian Funk; Daniel Chandramohan; François Chappuis; Daniel T Haydon
Journal:  PLoS Negl Trop Dis       Date:  2018-04-06

6.  Cost-effectiveness of algorithms for confirmation test of human African trypanosomiasis.

Authors:  Pascal Lutumba; Filip Meheus; Jo Robays; Constantin Miaka; Victor Kande; Philippe Büscher; Bruno Dujardin; Marleen Boelaert
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883

7.  Estimates of the duration of the early and late stage of gambiense sleeping sickness.

Authors:  Francesco Checchi; João A N Filipe; Daniel T Haydon; Daniel Chandramohan; François Chappuis
Journal:  BMC Infect Dis       Date:  2008-02-08       Impact factor: 3.090

Review 8.  Epidemiology of human African trypanosomiasis.

Authors:  Jose R Franco; Pere P Simarro; Abdoulaye Diarra; Jean G Jannin
Journal:  Clin Epidemiol       Date:  2014-08-06       Impact factor: 4.790

9.  Forecasting Human African Trypanosomiasis Prevalences from Population Screening Data Using Continuous Time Models.

Authors:  Harwin de Vries; Albert P M Wagelmans; Epco Hasker; Crispin Lumbala; Pascal Lutumba; Sake J de Vlas; Joris van de Klundert
Journal:  PLoS Comput Biol       Date:  2016-09-22       Impact factor: 4.475

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.